RxDoctor Payments Data

Tracey Kenneally

Family · Valhalla, NYNPI 1851957831

Payments from drug & device makers

$1,112in general payments, 2019–2025

Across 12 payments — averaging $92.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$816
  • Takeda Pharmaceuticals U.S.A., Inc.$125
  • Biogen$60
  • AstraZeneca$35
  • Boehringer Ingelheim$32
  • AbbVie$24
  • plus $21 from 1 others

What the payments were for

  • Consulting fees$605%
  • Speaking & faculty fees$75668%
  • Food & beverage$29627%

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,112 in reported general payments places this provider in the 70th percentile of 8,883 family providers in New York.

See all family providers in New York

Medicare billing

Part B allowed, 2024
$223,696
Medicare patients
52
Services billed
14,115

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Valhalla

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →